Who is sponsoring NCT04724174?

NCT04724174 is sponsored by Institut Paoli-Calmettes.

What drugs are being tested in NCT04724174?

Interventions in NCT04724174: pancreaticogastrostomy, pancreaticojejunostomy.

What condition does NCT04724174 study?

NCT04724174 studies Anastomosis; Complications, Pancreatic Fistula.

Is NCT04724174 still recruiting?

NCT04724174 is currently completed. Last updated 26 January 2021.

Last reviewed 2021-01-26 · How we verify

NCT04724174: GASTROPAN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pancreaticogastrostomy for High-Risk Pancreas

Completed Last updated 26 January 2021

What this trial tests

trial testing pancreaticogastrostomy in Anastomosis; Complications in 198 participants. Completed in 31 January 2020.

Timeline

1 June 2013

Primary endpoint
1 January 2020

31 January 2020

Quick facts

Lead sponsor	Institut Paoli-Calmettes
Status	Completed
Study type	OBSERVATIONAL
Enrollment	198
Start date	1 June 2013
Primary completion	1 January 2020
Estimated completion	31 January 2020

Drugs / interventions tested

pancreaticogastrostomy
pancreaticojejunostomy

Conditions studied

Anastomosis; Complications — all drugs for Anastomosis; Complications →
Pancreatic Fistula — all drugs for Pancreatic Fistula →

Sponsor

Institut Paoli-Calmettes — full company profile →

Who can join

18 and older, any sex, with Anastomosis; Complications or Pancreatic Fistula. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In 2013, a double purse-string telescoped pancreaticogastrostomy (PG) technique appeared to significantly reduce the risk of postoperative pancreatic fistula (POPF). This study compared the incidence of clinically relevant POPF in patients with high-risk anastomosis after undergoing PG or pancreaticojejunostomy (PJ) techniques.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Anastomosis; Complications

Currently open trials in the same condition.

NCT03148054 — Computed Tomography Vs. Endoscopy Study · recruiting

Other Institut Paoli-Calmettes trials

Trials by the same sponsor.

NCT07461142 — Reduction of Hematologic Toxicity in Locally Advanced Cervical Cancers · NA · not yet recruiting
NCT06557421 — De-Escalation Study Evaluating Venetoclax and Azacitidine Discontinuation in AML Responding Patients · Phase 2 · recruiting
NCT06046794 — Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients · NA · recruiting
NCT06055621 — Evaluation of DASATINIB Monotherapy Efficacy in Acute Myeloid Leukemia Patients Refractory to VENETOCLAX-AZACITIDINE · Phase 2 · recruiting
NCT05986071 — I/II Phase Study Evaluating M1774 in Combination With Fulvestrant in HR+ and HER2- Advanced Breast Cancers · Phase 1, PHASE2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04724174 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institut Paoli-Calmettes
Last refreshed: 26 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04724174.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing